Regenetp (STU:NJT) Change In Payables And Accrued Expense : €-2.78 Mil (TTM As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Regenetp Change In Payables And Accrued Expense?

Regenetp's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2023 was €0.33 Mil. It means Regenetp's Accounts Payable & Accrued Expense increased by €0.33 Mil from Dec. 2022 to Mar. 2023 .

Regenetp's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €-1.49 Mil. It means Regenetp's Accounts Payable & Accrued Expense declined by €1.49 Mil from Dec. 2021 to Dec. 2022 .

Regenetp Change In Payables And Accrued Expense Historical Data

The historical data trend for Regenetp's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Change In Payables And Accrued Expense Chart

Regenetp Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

1.86

1.14

-2.27

-0.93

-1.49

Regenetp Quarterly Data
	Apr18	Jul18	Oct18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.55	-2.57	-0.05	-0.49	0.33

Regenetp Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.78 Mil.

Regenetp Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Regenetp's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenetp (STU:NJT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (STU:NJT) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

RGTPQ:USA

Address

1960 South 4250 West, Salt Lake City, UT, USA, 84104

Website

https://www.polarityte.com

Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.

Regenetp (STU:NJT) Headlines

No Headlines